Human induced pluripotent stem cell-derived MGE cell grafting after status epilepticus attenuates chronic epilepsy and comorbidities via synaptic integration

Dinesh Upadhya,Bharathi Hattiangady,Olagide W Castro,Bing Shuai,Maheedhar Kodali,Sahithi Attaluri,Adrian Bates,Yi Dong,Su-Chun Zhang,Darwin J Prockop,Ashok K Shetty,Olagide W. Castro,Darwin J. Prockop,Ashok K. Shetty
DOI: https://doi.org/10.1073/pnas.1814185115
IF: 11.1
2018-12-17
Proceedings of the National Academy of Sciences
Abstract:Significance This study provides evidence that human induced pluripotent stem cell (hiPSC)-derived medial ganglionic eminence (MGE) cell grafting into the hippocampus after status epilepticus can greatly reduce the frequency of spontaneous seizures in the chronic phase through both antiepileptogenic and antiepileptic effects. The antiepileptogenic changes comprised reductions in host interneuron loss, abnormal neurogenesis, and aberrant mossy fiber sprouting, whereas the antiepileptic effects were evident from an increased occurrence of seizures after silencing of graft-derived interneurons. Additional curative impacts of grafting comprised improved cognitive and mood function. The results support the application of autologous human MGE cell therapy for temporal lobe epilepsy. Autologous cell therapy is advantageous as such a paradigm can avoid immune suppression and promote enduring graft–host integration.
multidisciplinary sciences
What problem does this paper attempt to address?